Neurapsyc, LLC develops neurotechnology and digital therapeutics for neurological rehabilitation, specializing in a proprietary wearable gait platform that uses asymmetric cueing and VR engagement for stroke and Parkinson's patients. The company also researches neuroplasticity-based therapeutics, combining digital and molecular approaches to enhance brain adaptability and recovery.
Funding
Funding not disclosed
Founders
Product
Problem
Stroke and Parkinson's patients often face limited, repetitive rehabilitation options that fail to fully leverage the brain's neuroplastic capacity, slowing recovery and reducing long-term functional gains. Existing gait training methods lack the precision and engagement needed to drive meaningful, lasting improvements in mobility and quality of life.
Solution
Neurapsyc provides a proprietary wearable gait rehabilitation platform that delivers asymmetric cueing to improve walking patterns in stroke and Parkinson's patients, with integrated VR for enhanced engagement and adherence. The company pairs this digital therapeutic approach with research into neuroplasticity-boosting molecules, creating a dual innovation strategy that targets both behavioral and biological pathways for recovery. By combining these modalities, Neurapsyc aims to deliver more personalized, effective rehabilitation that accelerates neuroplasticity-driven healing. Clinical development is supported through NIH-aligned translational research programs, connecting early-stage neuroscience discoveries with practical patient care.
Target Audience
Primary customers are stroke and Parkinson's patients in need of advanced gait rehabilitation, as well as rehabilitation clinics and clinical partners seeking science-driven, engaging therapeutic solutions.
Features
- Proprietary wearable platform using asymmetric cueing to target gait impairments specific to stroke and Parkinson's patients
- VR-enabled patient engagement to increase motivation, adherence, and immersion during rehabilitation sessions
- Neuroplasticity-based therapeutic research spanning both digital tools and molecular interventions to support brain adaptability
- Collaborative clinical development model partnering with academic inventors to scale patient-ready solutions
- Over a decade of translational expertise in neuroscience, biotech R&D, and clinical partnerships